Set an Asking Price
Last updated: Feb 2026 • Built for hospice, home health, and home care owners.
Pricing isn’t just a number. It’s a strategy. This step helps you understand valuation drivers, multiples, and risk factors so you don’t give away value (or stall the deal with unrealistic expectations).
Key takeaways
- Valuation is driven by earnings quality, risk, and proof, not rumor multiples.
- Terms can change your real outcome. Price alone is not the full story.
- A pricing range supported by data keeps leverage through diligence.
What you do in this step
Build a valuation foundation
- Understand the difference between revenue, EBITDA, and cash flow.
- Identify what your earnings look like after normalization (QoE mindset).
- Know the biggest value drivers (and the biggest price killers).
- Separate “asking price” from “net outcome” (terms matter).
Set a price that holds up
- Choose a pricing range based on buyer type (financial vs strategic).
- Plan for diligence pressure (how buyers will challenge assumptions).
- Decide what proof you need ready (KPIs, payer mix, retention, compliance).
- Align price strategy with timing and risk tolerance.
Vallexa resources for Step 2
How to value your healthcare business
High-level valuation concepts for hospice + home health sellers.
Hospice valuation: the process
What to expect—and how to protect value as scrutiny increases.
Top questions to ask before a valuation
How to avoid misleading comps and weak assumptions.
Valuation amid crackdowns & policy shifts
How compliance and regulatory risk shows up in price.
Multiples: what drives price
The levers that actually move the multiple (and the proof buyers need).
2026 valuation multiples report
Market context you can use without overfitting your expectations.
Medicare final rule: valuation & timing
How policy shifts impact buyer appetite and pricing pressure.
Hospice valuation in 2025: market shift
What changes when big buyers pause—and how to position anyway.
Step 2 FAQs: Asking Price & Valuation
What’s the difference between EBITDA and cash flow?
EBITDA is an operating earnings measure (before interest, taxes, depreciation, and amortization). Cash flow reflects what actually remains after necessary expenses and working capital needs. Buyers care about both—and how reliable they are.
What does “quality of earnings” mean for a seller?
It means your earnings are clean, repeatable, and well-supported. The clearer the story behind the numbers, the less buyers discount your valuation for uncertainty.
Why do “multiples” vary so much in healthcare services?
Because risk varies. Payer mix, compliance exposure, referral concentration, leadership depth, margins, and retention can all increase or reduce what buyers are willing to pay.
Should my asking price be higher than what I expect to get?
Not automatically. Overpricing can filter out serious buyers early. A better approach is a pricing range that’s justified—and supported by proof—so you keep leverage through diligence.
Do deal terms matter as much as price?
Often, yes. Earnouts, holdbacks, working capital adjustments, and timeline risk can change your real outcome even if the headline price looks strong.
What comes after pricing?
Step 3: attracting buyers—positioning, buyer targeting, and building momentum without compromising confidentiality.